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Cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) is hereditary
and caused by mutations in the NOTCH3 gene [1]. Typical
arterial wall changes in CADASIL are destruction of vascu-
lar smooth muscle cells (VSMC) and accumulation of gran-
ular osmiophilic material (GOM) and NOTCH3 protein
ectodomain at the VSMC surface [2]. These abnormalities
are already present in the (skin) vasculature of young adult
presymptomatic mutation carriers [3]. However, it is
unknown when arterial and VSMC abnormalities in
CADASIL initiate. The expression of NOTCH3 in VSMC
in the very early stages of development has recently been
reported by Ichinohe et al. [4]. The purpose of this study
was to investigate whether vessel wall abnormalities char-
acteristic for CADASIL are already detectable in a foetus
with a NOTCH3 mutation. We studied the vasculature of an
aborted 14-week-old foetus aVected by a NOTCH3 muta-
tion, and a control foetus of approximately the same gesta-
tional age, by means of histology, electron microscopy and
immunohistochemistry using a NOTCH3 monoclonal anti-
body (provided by Anne Joutel, Paris, France).
The foetal tissue was acquired through a termination of
pregnancy (TOP), after prenatal diagnosis via DNA-testing
in the chorionic villi. Prenatal testing was performed on
request from the parents, as one of them was a carrier of a
NOTCH3 mutation, with a positive family history for
CADASIL, and they did not wish to pass on the NOTCH3
mutation to their child. The foetus was found to be hetero-
zygous for the same common pathogenic NOTCH3 muta-
tion as its parent (p.Arg153Cys in exon 4). Oral and written
consent was given by the parents to use the foetal tissue for
CADASIL research purposes and approval was obtained
from the medical ethics committee of the Leiden University
Medical Center. The control foetus was obtained after an
elective TOP, according to the procedures of the medical
ethical committee approved protocol of donating foetal
material for scientiWc research after TOP. Autolysis time
was no more than 1 h. Tissue specimens were collected
from the fragmented tissue masses. From the CADASIL
foetus these included: brain, intestine, heart, liver, vertebra
and surrounding tissues, upper and lower extremity, pla-
centa and umbilical cord, and from the control foetus:
brain, lung, vertebra and surrounding tissues, upper and
lower extremity and placenta.
The tissues were formalin Wxed, embedded in paraYn
and stained with hematoxylin and eosin (H&E) and the
VerhoeV van Gieson (VvG) stain.
Immunostaining with monoclonal antibodies against
alpha smooth muscle actin (alpha-SMA; Progen, Heidel-
berg) and NOTCH3 1E4 was performed on all tissue speci-
mens of both the CADASIL and control foetus according to
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previously described techniques [3]. Brain tissue of a genet-
ically proven CADASIL patient served as a positive control
for the NOTCH3 staining. For ultrastructural examination,
tissues of the CADASIL foetus (brain, heart, extremity
(skin and muscle) and placenta) and the control foetus
(brain, lung, extremity (skin and muscle) and placenta)
were Wxed in 1.5% glutaraldehyde and 1% paraformalde-
hyde in cacodylate buVer, post-Wxed in 1% osmium tetrox-
ide and processed for Spurr embedding. Subsequently,
sections were cut, contrasted with uranyl acetate and lead
citrate and examined in a JEOL JEM-1011 electron micro-
scope. The examination focussed in particular on the pres-
ence of GOM or signs of (early) VSMC degeneration in the
blood vessels.
The material was well Wxed without signs of autolysis.
Neither the control nor the CADASIL foetal tissue showed
abnormalities on H&E and VvG staining, including the
vessels in the available brain tissue and peripheral tissues.
There were no thickened vessels or abnormal deposits in
the vessel walls (see Fig. 1a). Immunostaining did not
reveal positive NOTCH3 staining of vessels or other struc-
tures in any of the tissues that were examined. The positive
CADASIL control tissue consistently showed the typical
granular staining pattern of aVected vessel walls. All larger
vessels showed a regular positivity for alphaSMA (see
Fig. 1b, c). CADASIL foetal vessels did not contain GOM.
The morphology of the VSMC was not diVerent from that
of the control foetus. No changes were seen in other vascu-
lar wall structures, including the endothelium (see Fig. 1d).
The  Wnding of normal arterioles in an aVected foetus
suggests that arterial wall and VSMC abnormalities in
CADASIL initiate in the course of the Wrst two decades of
life. This is relevant for future studies aimed at unravelling
the pathophysiology of CADASIL and also implies that,
theoretically, early intervention, for example in the form of
genetic modulation therapy, could prevent or delay the
disease process.
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Fig. 1 Small cerebral vessel 
(a–c) and small subcutaneous 
vessel (d) of the foetus with a 
NOTCH3 mutation. Light 
microscopy shows a normal 
vessel wall in the H&E stain (a). 
Anti-alpha SMA demonstrates 
the presence of a normal smooth 
muscle layer (b) and 
anti-NOTCH3 staining is 
negative (c). Electron 
microscopy (£10,000) shows 
normal structured layers of the 
vessel, including the endothelial 
cells and pericyte (right) and 
some basement membrane 
material in between, without the 
presence of GOM or signs of 
degeneration (d)